Gene · 1361
Papers2,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Colorimetric Multimetabolite Assay for Quantitative Measurement of Keto Acids in Urine for At-Home Monitoring of Metabolic Disorders. | J Anal Methods Chem | 2026 | 41767879 | PubTator, text mining | PubMed |
| Genomic and clinical determinants of extraintestinal Clostridium perfringens infections in immunocompromised patients. | medRxiv | 2026 | 41757179 | PubTator, text mining | PubMed |
| Proteomic Insights into Venous Thromboembolism. | Med Sci (Basel) | 2026 | 41718141 | PubTator, text mining | PubMed |
| Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation. | Front Pharmacol | 2026 | 41635486 | PubTator, text mining | PubMed |
| From inhibition to regulation: serpins in health and disease. | Biomed J | 2026 | 41616576 | PubTator, text mining | PubMed |
| Cross-ancestry comparison of aptamer and antibody protein measures. | Nat Commun | 2026 | 41571639 | PubTator, text mining | PubMed |
| Computational analysis of the structural and functional impact of the deleterious nsSNPs in the human F2R gene and their implications in glioma. | Biochem Biophys Rep | 2026 | 41550510 | PubTator, text mining | PubMed |
| In vitro investigations of the clot formation and resolution properties of cryopreserved platelets. | Platelets | 2026 | 41537377 | PubTator, text mining | PubMed |
| Plasma proteomics biomarkers for predicting anti-tuberculosis drug-induced liver injury: A comprehensive assessment. | Br J Clin Pharmacol | 2026 | 41534953 | PubTator, text mining | PubMed |
| Association of Carboxypeptidase B2 Gene Polymorphisms With Graft Loss in Kidney Transplantation. | Transplant Direct | 2026 | 41531833 | PubTator, text mining | PubMed |
| Thromboinflammatory mediators produced by hyperfibrinolysis following injury. | J Trauma Acute Care Surg | 2026 | 41489548 | PubTator, text mining | PubMed |
| Lymphoblasts Express Hemostatic Factors: A Mechanism for Hypercoagulability in Pediatric Acute Lymphoblastic Leukemia. | Thromb Haemost | 2026 | 41086867 | PubTator, text mining | PubMed |
| Genotype characteristics and therapeutic efficacy trends in spontaneous intracerebral hemorrhage patients treated with intra-hematoma rt-PA thrombolysis. | Neurol Res | 2025 | 41474497 | PubTator, text mining | PubMed |
| Genetic Analysis of Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Single-Center Observational Study. | Genes (Basel) | 2025 | 41300788 | PubTator, text mining | PubMed |
| Integrated proteomic and metabolomic analysis elucidates the effects and mechanisms of Qiziyusi decoction on IVF outcomes in advanced maternal age infertility. | Front Endocrinol (Lausanne) | 2025 | 41141348 | PubTator, text mining | PubMed |
| Biomarker Analysis from the Compass Claudication Study - Rivaroxaban for Intermittent Claudication. | Clin Appl Thromb Hemost | 2025 | 41129724 | PubTator, text mining | PubMed |
| Altered fibrin clot properties and the risk of thromboembolism in women with obstetric antiphospholipid syndrome: a cohort study. | Pol Arch Intern Med | 2025 | 41117585 | PubTator, text mining | PubMed |
| The fibrinolytic system in disease: From molecular pathways to clinical outcomes. | Thromb Res | 2025 | 41109015 | PubTator, text mining | PubMed |
| Multi-Omics Feature Selection to Identify Biomarkers for Hepatocellular Carcinoma. | Metabolites | 2025 | 41002959 | PubTator, text mining | PubMed |
The Biological Variation in Serum ACE and CPN/CPB2 Activity in Healthy Individuals as Measured by the Degradation of Dabsylated Bradykinin-Reference Data and the Importance of Pre-Analytical Standardization. | Proteomes | 2025 | 40981200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1361/papers?page=2